...
首页> 外文期刊>Applied biochemistry and biotechnology, Part A. enzyme engineering and biotechnology >The pH Shift and Precursor Feeding Strategy in a Low-Toxicity FR-008/Candicidin Derivative CS103 Fermentation Bioprocess by a Mutant of Streptomyces sp. FR-008
【24h】

The pH Shift and Precursor Feeding Strategy in a Low-Toxicity FR-008/Candicidin Derivative CS103 Fermentation Bioprocess by a Mutant of Streptomyces sp. FR-008

机译:链霉菌属突变体在低毒性FR-008 / Candicidin衍生物CS103发酵生物过程中的pH改变和前体进料策略。 FR-008

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

CS103, the novel derivative of polyene macrolides antibiotic FR-008/candicidin with lower toxicity has been isolated from the culture mycelia of the mutant of Streptomyces sp. FR-008, with targeted deletions of the fscP cytochrome P450 gene from its chromosome. To enhance biosynthesis of CS103, pH shift and precursor feeding strategy for fermentation process by the mutant of Streptomyces sp. FR-008 in a stirred tank bioreactor was developed. According to the process parameters analysis, the effectiveness of the strategy was examined and confirmed by experiments. A maximal CS103 concentration of 139.98 μg/mL was obtained, 2.05-fold higher than that in the pHuncontrolled fermentation. Compared to other three cases as pH-uncontrolled, pHcontrolled, and two-stage pH-controlled batch cultures, the proposed “pH shift and precursor feeding strategy” effectively avoided the scarcity of the antibiotic precursor, increased the CS103 yield from biomass (YP/X) and substrate (YP/S) by 110.61% and 48.52%, respectively, and at the time the fermentation time was shortened from 120 to 96 h. The highest CS103 production rate (1.46 μg mL1 h1) of the pH shift and precursor feeding strategy was 284.21%, 97.30%, and 58.70% higher than that of pH-uncontrolled, pH-controlled, and two-stage pH-controlled batch culture cases, respectively.
机译:CS103,一种具有较低毒性的多烯大环内酯类抗生素FR-008 / candicidin的新型衍生物,已从链霉菌属(Streptomyces sp。)突变体的菌丝体中分离得到。 FR-008,其染色体上的fscP细胞色素P450基因有针对性地缺失。为了增强CS103的生物合成,通过链霉菌sp。的突变体发酵过程的pH值变化和前体补料策略。开发了搅拌釜生物反应器中的FR-008。根据工艺参数分析,通过实验验证了该策略的有效性。获得的最大CS103浓度为139.98μg/ mL,比pH不受控制的发酵高2.05倍。相较于其他三种情况,如pH不受控制,pH控制和两阶段pH控制的分批培养,建议的“ pH转换和前体进料策略”有效避免了抗生素前体的短缺,增加了生物质的CS103产量(YP / X)和底物(YP / S)分别降低110.61%和48.52%,并且此时的发酵时间从120小时缩短至96小时。 pH改变和前体进料策略的最高CS103生产率(1.46μgmL1 h1)比不受pH控制,受pH控制和两阶段受pH控制的分批培养分别高284.21%,97.30%和58.70%案件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号